Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EMPIRE BIO A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   0.7% 0.8% 1.5% 1.9% 2.8% 3.0% 9.6% 9.4%   Credit score (0-100)   95 94 76 69 59 56 26 26   Credit rating   AA AA A A BBB BBB BB BB   Credit limit (kDKK)   1,198.8 1,091.1 38.9 2.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,281 10,821 6,734 6,072 6,159 6,140 0.0 0.0   EBITDA   4,696 5,188 1,553 1,033 725 598 0.0 0.0   EBIT   4,069 4,360 621 202 -82.3 -271 0.0 0.0   Pre-tax profit (PTP)   4,039.2 4,276.9 585.5 160.0 -111.2 -271.0 0.0 0.0   Net earnings   3,148.6 3,334.6 451.6 125.3 -84.6 -210.0 0.0 0.0   Pre-tax profit without non-rec. items   4,039 4,277 586 160 -111 -271 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,808 5,453 4,919 4,756 4,205 4,343 0.0 0.0   Shareholders equity total   6,943 7,278 4,729 4,854 4,770 4,560 3,180 3,180   Interest-bearing liabilities   78.4 60.7 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,340 10,204 12,337 10,990 8,739 7,422 3,180 3,180   Net Debt   -4,771 -2,246 -6,139 -4,344 -2,548 -1,271 -3,180 -3,180     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,281 10,821 6,734 6,072 6,159 6,140 0.0 0.0   Gross profit growth   8.2% 5.2% -37.8% -9.8% 1.4% -0.3% -100.0% 0.0%   Employees   11 11 11 11 11 11 0 0   Employee growth %   10.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,340 10,204 12,337 10,990 8,739 7,422 3,180 3,180   Balance sheet change%   7.1% -1.3% 20.9% -10.9% -20.5% -15.1% -57.2% 0.0%   Added value   4,696.4 5,188.5 1,552.9 1,032.7 748.5 598.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -680 1,816 -1,466 -994 -1,358 -732 -4,343 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   39.6% 40.3% 9.2% 3.3% -1.3% -4.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   40.7% 42.4% 5.5% 1.7% -0.8% -3.4% 0.0% 0.0%   ROI %   61.7% 59.8% 10.0% 4.0% -1.7% -5.8% 0.0% 0.0%   ROE %   49.4% 46.9% 7.5% 2.6% -1.8% -4.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   68.6% 72.7% 39.0% 45.1% 56.0% 63.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -101.6% -43.3% -395.3% -420.6% -351.6% -212.4% 0.0% 0.0%   Gearing %   1.1% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   39.1% 118.9% 117.2% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 1.3 0.9 0.9 0.9 0.8 0.0 0.0   Current Ratio   2.1 1.4 0.9 0.9 1.0 0.8 0.0 0.0   Cash and cash equivalent   4,849.2 2,306.3 6,139.4 4,343.8 2,547.7 1,270.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,506.1 1,185.5 -749.4 -476.0 -55.7 -476.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   427 472 141 94 68 54 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   427 472 141 94 66 54 0 0   EBIT / employee   370 396 56 18 -7 -25 0 0   Net earnings / employee   286 303 41 11 -8 -19 0 0